At CVS's Annual General Meeting on 18 November 2025, Resolution 3 (the Directors' Remuneration Report) was passed with 77.7% of votes in favour.
In accordance with Provision 4 of the FRC's 2024 UK Corporate Governance Code, the Company has released this statement to provide an update to shareholders on the actions taken and the views received from shareholders, following the vote.
The Chair of the Remuneration Committee engaged with those shareholders who voted against this resolution in early 2026 to understand their concerns. The Company provided further explanations and information to address some of the shareholders concerns ahead of the additional steps outlined below.
Following the Company's admission to the Main Market of the London Stock Exchange in January 2026, the Company has carried out an extensive consultation with shareholders in relation to its Director's remuneration, including its Directors' Remuneration Policy which will be put to a binding AGM resolution at its 2026 AGM.
The Board would like to thank shareholders who have taken part in the engagement process and is reflecting on the feedback received. A final update will be published in our 2026 Annual Report, in accordance with the UK Corporate Governance Code.
Attachments
- Original document
- Permalink
Disclaimer
CVS Group plc published this content on May 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 15, 2026 at 14:03 UTC.
